Gja1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Gja1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GJA1 encodes Connexin-43 (Cx43), the most abundant gap junction protein in the mammalian brain. Gap junctions allow direct intercellular communication by permitting the passage of ions, small molecules, and second messengers between adjacent cells.
| Attribute | Value |
|---|---|
| Symbol | GJA1 |
| Full Name | Gap Junction Protein Alpha 1 |
| Alias | Connexin 43 (Cx43) |
| Chromosomal Location | 6q22.31 |
| NCBI Gene ID | 2697 |
| OMIM ID | 121014 |
| Ensembl ID | ENSG00000152661 |
| UniProt ID | P17302 |
Connexin-43 is a 43 kDa transmembrane protein that assembles into hexameric hemichannels (connexons). When two hemichannels from adjacent cells dock, they form a complete gap junction channel. Each gap junction channel allows the passage of molecules up to ~1 kDa, including ions (Ca²⁺, Na⁺, K⁺), cyclic AMP, ATP, and small signaling molecules 1.
In the brain, Cx43 is predominantly expressed in astrocytes, where it plays crucial roles in:
Gap junction dysfunction is increasingly recognized in AD pathophysiology. Cx43 expression and function are altered in AD brain tissue and mouse models. Amyloid-beta peptides can directly impair gap junction communication, disrupting astrocytic networks and contributing to synaptic dysfunction 3. Restoring gap junction function has shown promise in preclinical AD models.
Cx43 alterations have been documented in Parkinson's disease, particularly in the substantia nigra. Gap junction dysfunction may contribute to dopaminergic neuron vulnerability and neuroinflammation 4.
During ischemic stroke, Cx43 hemichannels can open inappropriately, allowing toxic calcium influx and contributing to cell death. Cx43 blockers have shown neuroprotective effects in stroke models 5.
Altered Cx43 expression and function are observed in epileptic tissue. Gap junction coupling may contribute to synchronous neuronal firing during seizures.
GJA1 is widely expressed throughout the brain, with highest levels in astrocytes. It is also expressed in leptomeninges, endothelial cells, and certain neuronal populations. Peripheral expression includes heart, ovaries, testis, and skin.
Targeting Cx43 offers therapeutic opportunities:
Gja1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Gja1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.